Zero Fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for Right Atrial Arrhythmias
- Conditions
- Atrial Premature ComplexesAtrial ArrhythmiaAtrial Tachycardia
- Interventions
- Procedure: Zero-fluoroscopy ablationProcedure: Conventional fluoroscopy ablation
- Registration Number
- NCT03151278
- Lead Sponsor
- Tongji Hospital
- Brief Summary
This study is intended to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach with conventional fluoroscopic approach as performing catheter ablation of right atrial arrhythmias.
- Detailed Description
Catheter ablation is a well-established treatment to treat patients with a wide range of heart rhythm disturbances.
Fluoroscopy is the imaging modality routinely used for cardiac device implantation and electrophysiological procedures. Due to the rising concern regarding the harmful effects of radiation exposure to both the patients and operation staffs, novel three-dimensional mapping systems such as Ensite NavX have been developed and implemented in electrophysiological procedure for the navigation of catheters inside the heart chambers.
Ensite NavX is a promising system to guide catheters inside the cardiac chambers and vessels without the use of fluoroscopy.
This study is intended to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach with conventional fluoroscopic approach as performing catheter ablation of right atrial arrhythmias.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 212
- Atrial Tachycardia
- Atrial Premature Complexes
- Left Atrial Premature Complexes
- Left Atrial Tachycardia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Zero-fluoroscopy ablation Zero-fluoroscopy ablation Atrial arrhythmias will be mapped and ablated under the guidance of three-dimensional mapping system without fluoroscopy. Conventional fluoroscopy ablation Conventional fluoroscopy ablation Atrial arrhythmias will be mapped and ablated under fluoroscopic guidance plus three-dimensional mapping system.
- Primary Outcome Measures
Name Time Method Total success rates 3 months The patients have no related arrhythias or recurrence during follow up.
- Secondary Outcome Measures
Name Time Method Total procedure time during procedure The patients have no related arrhythias or recurrence during follow up.
Recurrence rate 6 months The patients have no related arrhythias or recurrence during follow up.
Immediate success rate 24 hours Electrophysiologic study shows success of ablation
Fluoroscopy time during procedure From skin puncture to withdrawal of all the catheters.
Complications 6 months The patients have no related complications during follow up.
Trial Locations
- Locations (1)
Tongji Hospital
🇨🇳Wuhan, Hubei, China